InvestorsHub Logo
Followers 0
Posts 30
Boards Moderated 0
Alias Born 09/26/2017

Re: None

Saturday, 04/21/2018 1:53:24 PM

Saturday, April 21, 2018 1:53:24 PM

Post# of 2490
April 20th 2018 - The Best Stock Investment For 2018 - Mymetics Corp. (MYMX)

" Mymetics Corp (MYMX) and Sanofi are currently working on a redesigned study to compare the immunogenicity of Mymetics’ influenza virosomes with that of Sanofi Pasteur’s egg-based split vaccine."

https://askwarrenbuffet.blogspot.com/2018/02/the-best-investment-for-2018-is.html

Surprisingly, they didn't mention MACIVIVA!
Mymetics is leading a consortium of 4 other companies.
MACIVIVA = Game Changer = Disrupting the vaccine industry worldwide!

MACIVIVA latest Progress' Reporting Period Posted: https://cordis.europa.eu/result/rcn/194900_en.html
Copy of latest MACIVIVA presentation (downloadable): https://www.mymetics.com/media-center/world-vaccine-congress-10-12-october-2017-barcelona/

Would have been better in the hands of the Americans pps wise since 2012?
Dr. Christopher Henney, currently Director of Cyclacel Pharmaceuticals and chairman of BOD at Cascadian Therapeutics(CSCA)(formerly Oncothyreon)-recently acquired by Seattle Genetics, and Anthera Pharmaceuticals(ANTH); and former Dendreon co-founder & CEO was once on board with this unknown microcap as Chairman of BOD but seems like had a disagreement with the largest shareholder that led him and his Dendreon protege to leave in less than a year.
https://www.xconomy.com/san-francisco/2012/04/11/mymetics-ropes-in-dendreon-kpcb-vets-to-restart-vaccine-developer/
Less
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYCC News